Research Topics
| O BruyereSummaryCountry: Belgium Publications
| Collaborators
|
Detail Information
Publications
Impact of chondroitin sulphate on health utility in patients with knee osteoarthritis: towards economic analysisO Bruyere
Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU Sart Tilman, Liege, Belgium
J Med Econ 12:356-60. 2009..The second objective was, using these data, to conduct economic analyses...
Vitamin D inadequacy in Belgian postmenopausal osteoporotic womenAudrey Neuprez
Department of Epidemiology, Public Health and Health Economics, University of Liege, 4020 Liege, Belgium
BMC Public Health 7:64. 2007..Opinions with regard to the definition of vitamin D deficiency and adequate vitamin D status vary widely and there are no clear international agreements on what constitute adequate concentrations of vitamin D...
Effects of strontium ranelate on spinal osteoarthritis progressionO Bruyere
University of Liege, Department of Public Health, Epidemiology, and Health Economics, CHU Sart Tilman, Bat B23, 4000 Liege, Belgium
Ann Rheum Dis 67:335-9. 2008..The aim of this study was to determine whether a 3-year treatment with strontium ranelate could delay the progression of spinal osteoarthritis (OA)...
Highest prevalence of vitamin D inadequacy in institutionalized women compared with noninstitutionalized women: a case-control studyOlivier Bruyere
University of Liege, Department of Public Health, Epidemiology and Health Economics, CHU Sart Tilman, Bat B23, 4000 Liege, Belgium
Womens Health (Lond Engl) 5:49-54. 2009..We believe that a greater awareness of the importance of vitamin D inadequacy is needed in order to address this public health problem...
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE systemOlivier Bruyere
WHO Collaborating Center for the Public Health Aspect of Musculoskeletal Disorders, University of Liege, Belgium
BMC Musculoskelet Disord 9:165. 2008..Symptomatic slow-acting drugs (SYSADOA) have been largely studied over the last decade. The objective of this study is to prepare a document providing recommendations for the use of SYSADOA in osteoarthritis (OA)...
Vitamin D status and response to antiosteoporotic therapyOlivier Bruyere
University of Liege, Department of Public Health, Epidemiology and Health Economics, CHU Sart Tilman, Bat B23, 4000 Liege, Belgium
Womens Health (Lond Engl) 4:445-7. 2008..Moreover, the adjusted odds ratio for incident fractures in vitamin D-deficient as compared with vitamin D-repleted women was 1.77 (95% CI: 1.20-2.59; p = 0.004)...
Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelateO Bruyere
Department of Epidemiology, Public Health and Health Economics, University of Liege, Belgium
Curr Med Res Opin 23:3041-5. 2007..The objective of this study is to analyse the association between BMD changes and hip fracture incidence during treatment with SR...
Post-fracture management of patients with hip fracture: a perspectiveO Bruyere
Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Curr Med Res Opin 24:2841-51. 2008..After surgery, many patients experience long-term disability or die as a consequence of the fracture. A fracture is a major risk factor for a subsequent fracture, which may occur within a short interval...
Low dietary calcium in European postmenopausal osteoporotic womenOlivier Bruyere
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders and Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Public Health Nutr 12:111-4. 2009..The WHO recommends a daily Ca intake for postmenopausal women of 1300 mg. The objective of the present study was to assess the dietary Ca intake in European postmenopausal osteoporotic women...
Three year joint space narrowing predicts long term incidence of knee surgery in patients with osteoarthritis: an eight year prospective follow up studyO Bruyere
Department of Public Health, Epidemiology and Health Economics, University of Liege, Bat B23, 4000 Liege, Belgium
Ann Rheum Dis 64:1727-30. 2005..To assess the clinical relevance of mean and minimum femorotibial joint space narrowing (JSN) for predicting future osteoarthritis related surgery in patients with knee osteoarthritis...
Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelateOlivier Bruyere
World Health Organization Collaborating Center for Public Health Aspect of Osteoarticular Disorders, University of Liege, B 4000 Liege, Belgium
J Clin Endocrinol Metab 92:3076-81. 2007..Our objective was to analyze the relationship between bone mineral density (BMD) changes and fracture incidence during 3-yr treatment with strontium ranelate...
Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trialsO Bruyere
Department of Public Health, Epidemiology and Health Economics, University of Liege, Belgium
Osteoarthritis Cartilage 16:254-60. 2008..To assess the incidence of Total Joint Replacement (TJR) during the long-term follow-up of patients with knee osteoarthritis (OA) formerly receiving treatment with glucosamine sulphate or placebo...
Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal womenOlivier Bruyere
Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU Sart Tilman, Bat B23, 4000, Liege, Belgium
Eur J Epidemiol 24:707-12. 2009..However, spine BMD changes do not influence vertebral fracture incidence...
Longitudinal study of magnetic resonance imaging and standard X-rays to assess disease progression in osteoarthritisO Bruyere
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, University of Liege, Liege, Belgium
Osteoarthritis Cartilage 15:98-103. 2007..To investigate, over 1-year, the relationship between X-ray and magnetic resonance imaging (MRI) findings in patients with knee osteoarthritis (OA)...
Biochemical markers in glucocorticoid-induced osteoporosisO Bruyere
Department of Public Health and Epidemiology, and Bone and Cartilage Research Unit, University of Liege, Belgium
Front Horm Res 30:49-59. 2002
Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)O Bruyere
Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Osteoporos Int 23:193-9. 2012..This paper defines health claims related to bone health and provides guidelines for the design and the methodology of clinical studies to support claims...
Prevalence of vitamin D inadequacy in European postmenopausal womenO Bruyere
WHO Collaborating Center for Public Health Aspect of Osteoarticular Disorders and Department of Public Health, Epidemiology and Health Economics, University of Liege, Belgium
Curr Med Res Opin 23:1939-44. 2007..There are no clear international agreements on what constitutes a level of vitamin D inadequacy, but recent publications suggest that the circulating level of vitamin D should be over 80 nmol/L or at least between 50 and 80 nmol/L...
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 yearsO Bruyere
Department of Public Health, Epidemiology and Health Economics, CHU Sart Tilman, University of Liege, Bat B23, 4000 Liege, Belgium
Osteoporos Int 21:1031-6. 2010....
Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective studyO Bruyere
University of Liege, Department of Public Health, Epidemiology and Health Economics, CHU Sart Tilman, 4000 Liege, Belgium
Ann Rheum Dis 65:1050-4. 2006..To investigate the relation between biochemical markers of bone, cartilage, and synovial remodelling and the structural progression of knee osteoarthritis...
Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritisOlivier Bruyere
WHO Collaborating Center for Public Health Aspect of Osteoarticular Disorders, University of Liege, Liege, Belgium
Drugs Aging 24:573-80. 2007..With respect to the structure-modifying effect, there is compelling evidence that glucosamine sulfate and chondroitin sulfate may interfere with progression of OA...
Controlled whole body vibration to decrease fall risk and improve health-related quality of life of nursing home residentsOlivier Bruyere
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Liege, Belgium
Arch Phys Med Rehabil 86:303-7. 2005..To investigate the effects of whole body vibration in the elderly...
Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture riskJ Y Reginster
CHU Centre Ville, Liege, Belgium
Bone 34:344-51. 2004..In conclusion, a 1-year decrease in PINP, BSAP, or OC, but not CTx/Cr, may be predictive of the 3-year VF risk reduction with raloxifene therapy in this subset of postmenopausal women with osteoporosis...
Assessment of determinants for osteoporosis in elderly menS Scholtissen
Department of Public Health, Epidemiology and Health Economics, University of Liege, Sart Tilman, Belgium
Osteoporos Int 20:1157-66. 2009....
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trialJ Y Reginster
Bone and Cartilage Metabolism Research Unit WHO Collaborating Center for Public Aspects of Osteoarticular Disorders, University of Liege, Belgium
Lancet 357:251-6. 2001..Treatment of osteoarthritis is usually limited to short-term symptom control. We assessed the effects of the specific drug glucosamine sulphate on the long-term progression of osteoarthritis joint structure changes and symptoms...
Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnoverJ Collette
Department of Clinical Biology, Bone and Cartilage Markers Laboratory, University of Liege, Liege, Belgium
Osteoporos Int 21:233-41. 2010..The vertebral anti-fracture efficacy of strontium ranelate was shown to be independent of baseline bone turnover levels...
Subchondral tibial bone mineral density predicts future joint space narrowing at the medial femoro-tibial compartment in patients with knee osteoarthritisO Bruyere
WHO Collaborating Center for Public Health Aspect of Osteoarticular Disorders, 4000 Liege, Belgium
Bone 32:541-5. 2003..61 +/- 0.69 mm versus -0.13 +/- 0.27 mm; p = 0.03). Assessment of BMD of the subchondral tibial bone is significantly correlated with future joint space narrowing and could be used as a predictor of knee osteoarthritis progression...
Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from BelgiumF Richy
University of Liege, Faculty of Medicine, Department of Public Health, Public Health and Epidemiology Unit, WHO Collaborating Center for Public Aspects of Osteoarticular Disorders, Belgium
QJM 97:39-46. 2004..Risk indices have been developed to identify women at risk of low bone mineral density (BMD) who should undergo BMD testing. Aim: To compare the performance of four risk indices in White ambulatory women in Belgium...
Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 yearsJ Y Reginster
Department of Public Health Sciences, University of Liege, Liege, Belgium
Bone 45:1059-64. 2009..This article describes the efficacy, safety, and tolerability of this agent over 8 years...
Current role of glucosamine in the treatment of osteoarthritisJ Y Reginster
WHO Collaborating Center, Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Rheumatology (Oxford) 46:731-5. 2007..To evaluate the interest of using the various preparations of glucosamine for symptomatic and structural management of osteoarthritis (OA)...
Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysisF Richy
Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Calcif Tissue Int 76:176-86. 2005..In this setting, D analogs seem to prevent spinal fractures to a greater extent than do native vitamin D, but this assumption should be confirmed on a comprehensive basis in multiarm studies including an inactive comparator...
Strontium ranelate in the prevention of osteoporotic fracturesJ Y Reginster
Bone and Cartilage Metabolism Unit, University of Liege, Liege, Belgium
Int J Clin Pract 61:324-8. 2007..A preplanned analysis of a sub-group of patients aged 80 years and over showed that, currently, strontium ranelate is the only antiosteoporotic agent to reduce vertebral and non-vertebral fractures in this age group...
Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regressionV Rabenda
Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU Bât B23, 4000 Liege, Belgium
Osteoporos Int 22:893-901. 2011..Our results suggest that bone mineral density (BMD)changes cannot be used as a surrogate of anti-fracture efficacy, among patients receiving calcium, with or without vitamin D...
Evidence of nutriceutical effectiveness in the treatment of osteoarthritisJ Y Reginster
Bone and Cartilage Metabolism Research Unit, CHU Centre Ville, Policliniques L Brull, Quai Godefroid Kurth 45 9 ème étage, 4020 Liege, Liege, Belgium
Curr Rheumatol Rep 2:472-7. 2000..An important issue is that all the conclusive studies with such chemical entities resulted from the use of prescription medicines, and not over-the-counter pills or food supplements...
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosisJ Y Reginster
Department of Public Health and Health Economics, University of Liege, Liege, Belgium
Osteoporos Int 23:1115-22. 2012..01). Vertebral and nonvertebral fracture incidence was lower between 5 and 10 years than in a matched placebo group over 5 years (P?<?0.05). Strontium ranelate's antifracture efficacy appears to be maintained long term...
Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamolS Scholtissen
Department of Public Health, University of Liege, Liege, Belgium
Int J Clin Pract 64:756-62. 2010..For this purpose, a 6-month time horizon and a health care perspective was used...
Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic womenM Hiligsmann
Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Osteoporos Int 21:157-65. 2010..The results of this study suggested that long-term treatment with strontium ranelate over 5 years is cost-effective compared to no treatment for postmenopausal osteoporotic women...
Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfateO Bruyere
WHO Collaborating Center for Public Health Aspect of Osteoarticular Disorders, Liege, Belgium
Osteoarthritis Cartilage 11:1-5. 2003..Such patients may be particularly responsive to structure-modifying drugs...
Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approachF Richy
Santé Publique, épidémiologie et économie de la santé, CHU, Bat B23, B 4000 Sart Tilman, Belgium, Europe
Ann Rheum Dis 63:759-66. 2004..To provide an updated document assessing the global, NSAID-specific, and time dependent risk of gastrointestinal (GI) complications through meta-analyses of high quality studies...
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)O Bruyere
Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Osteoporos Int 21:713-22. 2010..This paper provides recommendations for fair and unbiased relationship between academic scientists and the pharmaceutical industry...
[Economic evaluation of osteoporosis screening strategy conducted in the Province of Liège with the cooperation of Liège Province Santé]M Hiligsmann
Département d Economie, HEC ULg, Universite de Liege, Belgique
Rev Med Liege 63:588-94. 2008..Furthermore, to improve the efficiency of the screening strategy, we suggest to target screening on women with one or more clinical risk factors, or on women aged 65 years and older...
[A FRAX model for the assessment of fracture probability in Belgium]A Neuprez
Département des Sciences de la Santé Publique, Service de Sante Publique, épidémiologie et économie de la santé, Faculte de Medecine, Universite de Liege
Rev Med Liege 64:612-9. 2009..The approach will need to be supported by health economic analyses...
[Glucosamine as a pain-modifying drug in osteorthritis. What's new in 2006]J Y Reginster
Service de Sante Publique, épidémiologie et économie de la santé
Rev Med Liege 61:169-72. 2006..Their results are supported by new pharmacokinetic and preclinical studies, explaining the mode of action of glucosamine in osteoarthritis...
[Long-term risk of osteoporotic fracture in Belgium]M Hiligsmann
Département d Economie, HEC ULg, Universite de Liege
Rev Med Liege 63:480-7. 2008..9% and 14.8% and for osteoporotic women 32.3% and 53.4%. Our lifetime risk estimates re-emphasize that osteoporosis is a major public health problem and that its societal burden is likely to increase due to demographic changes...
Effect of collagen hydrolysate in articular pain: A 6-month randomized, double-blind, placebo controlled studyO Bruyere
Department of Public Health, Epidemiology and Health Economics, University of Liege, Belgium
Complement Ther Med 20:124-30. 2012..Evaluation of the efficacy and safety of a food supplement made of collagen hydrolysate 1200mg/day versus placebo during 6 months, in subjects with joint pain at the lower or upper limbs or at the lumbar spine...
Health claims assessment in the field of joint and cartilage: a consensus viewpoint of the Group for the Respect of Ethics and Excellence in ScienceO Bruyere
Department of Public Health, Epidemiology and Health Economics, University of Liege, Belgium
Curr Med Res Opin 28:611-6. 2012....
Primary prevention of osteoporosis: mass screening scenario or prescreening with questionnaires? An economic perspectiveFlorent Richy
University of Liege, Faculty of Science, Department of Public Health, Epidemiology and Health Economics, CHU B23 Sart Tilman B 4000, Belgium
J Bone Miner Res 19:1955-60. 2004..Our results show that certain prescreening strategies are more efficient than DXA-based approaches. These results are of considerable value for health policy decision-makers and the scientific community...
Radiologic features poorly predict clinical outcomes in knee osteoarthritisOlivier Bruyere
WHO Collaborating Center for Public Health Aspect of Osteoarticular Disorders, Liege, Belgium
Scand J Rheumatol 31:13-6. 2002..CONCLUSION: Radiographic and clinical progressions of the disease are significantly associated but the clinical relevance of the association is questionable...
Current concepts in the therapeutic management of osteoarthritis with glucosamineJean-Yves Reginster
WHO Collaborating Center for Public Health Aspects of Rheumatic Diseases, Liege, Belgium
Bull Hosp Jt Dis 63:31-6. 2005....
Strontium ranelate normalizes bone mineral density in osteopenic patientsOlivier Malaise
WHO Collaborating Center for Public Health Aspect of Osteoarticular Disorders, University of Liege, Liege, Belgium
Aging Clin Exp Res 19:330-3. 2007..To assess the capacity of strontium ranelate to restore normal bone mineral density (WHO definition: T-score >or=-1) in post-menopausal osteopenic women (T-score between -1 and -2.5) at baseline...
Combination/sequential therapy in osteoporosisMarie-Paul Lecart
Bone and Cartilage Metabolism Research Unit, CHU Centre-Ville, Policliniques L. BRULL, Quai Godefroid Kurth 45 (9th floor, 4020 Liege, , Belgium
Curr Osteoporos Rep 2:123-30. 2004..Long-term clinical studies, using fractures as an endpoint should be initiated to better understand the clinical and pharmaco-economic interest of combination therapies in the management of osteoporosis...
Strontium ranelate (Fujisawa/Servier)Isabelle Jupsin
Bone and Cartilage Metabolism Research Unit. CHU Centre-Ville, Policliniques L Brull, Quai Godefroid Kurth 45, , Belgium
Curr Opin Investig Drugs 6:435-44. 2005..Fujisawa Pharmaceutical is developing the drug in Japan; in November 2004, phase II Japanese trials were ongoing...
Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic womenOlivier Bruyere
WHO Collaborating Center for Public Health Aspect of Osteoarticular Disorders, Liege, Belgium
Maturitas 44:259-65. 2003..CONCLUSION: We conclude that two sequential measurements of BGP and U-CTX performed at 3-months intervals could be of interest to identify postmenopausal osteoporotic women with the highest risk to present new vertebral deformities...
Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic reviewFlorent Richy
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Liege, Belgium
Osteoporos Int 14:179-90. 2003..These findings could have practical implication in the long-term management of asthmatic and COPD patients...
Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysisFlorent Richy
Faculty of Medicine, Department of Public Health, Public Health and Epidemiology, , , Belgium
Arch Intern Med 163:1514-22. 2003....
Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritisEric Abadie
Department of Registration and Clinical Studies, French Agency For the Safety of Health Products (AFSSAPS, France
Osteoarthritis Cartilage 12:263-8. 2004..Although these guidelines are subject to change as new information becomes available, the information above is based on the present knowledge in the field with the addition of expert opinion...
Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studiesOlivier Bruyere
WHO Collaborating Center for Public Health Aspect of Osteoarticular Disorders, Liege, Belgium
Menopause 11:138-43. 2004....
Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapyJean-Yves Reginster
Bone 42:832-6. 2008....
Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rateFlorent Richy
Department of Public Health, Faculty of Medicine, University of Liege, Epidemiology and Health Economics, WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Liege, Belgium
Osteoporos Int 15:301-10. 2004..Their efficacy in reducing the number of fractures in patients exposed to CS remains to be determined...
Symptom and structure modifying properties of chondroitin sulfate in osteoarthritisJean Yves Reginster
Department of Public Health Economics, University of Liege, Liege, Belgium
Mini Rev Med Chem 7:1051-61. 2007..CS exhibits a wide range of biological activities. Many experimental and clinical data are available, affirming that CS represents an effective and safe symptomatic treatment of osteoarthritis (OA) with delayed and sustained effects...
Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritisJean Yves Reginster
Bone and Cartilage Metabolism Research Unit, University of Liege, Belgium
Curr Opin Rheumatol 15:651-5. 2003..Several entities have been investigated carefully for the symptomatic and structural management of osteoarthritis. This review reports recent findings suggesting that such compounds may delay the structural progression of osteoarthritis...
New perspectives in the management of osteoarthritis. structure modification: facts or fantasy?Jean Yves Reginster
Bone and Cartilage Metabolism Research Unit, University of Liege, CHU Centre Ville, Policliniques L Brull, Liege, Belgium
J Rheumatol Suppl 67:14-20. 2003..An important issue is that all conclusive studies with such chemical entities resulted from the use of prescription medicines and not over-the-counter or nutriceutical supplements...
Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritisOlivier Bruyere
WHO Collaborating Center for Public Health Aspect of Osteoarticular Disorders (CCPHAOD, Liege, Belgium
J Rheumatol 30:1043-50. 2003..11 (0.83) mm in patients in the highest quartile (> +14.34 ng/ml) (p = 0.03). CONCLUSION: The 3-year radiological progression of knee OA could be predicted by a 1-year increase in OC or a 1-year decrease in HA levels...
Clinical significance of the long-term symptom-modifying effects of glucosamine sulfate: comment on the article by Brandt and MazzucaOlivier Bruyere
Arthritis Rheum 54:2339-41; author reply 2341-3. 2006
